Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Norris Medicines Ltd has submitted a compliance certificate confirming that share dematerialization requests were properly processed during Q4 FY2026 (January-March 2026). The Registrar and Transfer Agent, Purva Sharegistry (India) Pvt Ltd, confirmed that physical share certificates received for dematerialization were verified, mutilated, cancelled, and depositories were substituted as registered owners within prescribed timelines. The filing includes a detailed list of 20 shareholders who converted physical certificates to dematerialized form during the quarter, with share quantities ranging from 30 to 1,740 shares per transaction.
This is a routine regulatory compliance filing with no direct impact on stock price or shareholder value. It simply confirms proper processing of physical-to-dematerialized share conversions as mandated by SEBI regulations.